CLPT
CLPT
NASDAQ · Health Care

Clearpoint Neuro Inc

$8.82
-0.32 (-3.50%)
Financial Highlights (FY 2026)
Revenue
35.43M
Net Income
-21,349,939
Gross Margin
60.9%
Profit Margin
-60.3%
Rev Growth
+24.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.9% 60.9% 53.8% 53.8%
Operating Margin -62.9% -56.6% 16.4% 17.6%
Profit Margin -60.3% -57.2% 15.4% 15.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 35.43M 28.48M 158.88M 142.75M
Gross Profit 21.59M 17.35M 85.53M 76.84M
Operating Income -22,290,726 -16,125,434 26.07M 25.18M
Net Income -21,349,939 -15,444,855 24.47M 21.58M
Gross Margin 60.9% 60.9% 53.8% 53.8%
Operating Margin -62.9% -56.6% 16.4% 17.6%
Profit Margin -60.3% -57.2% 15.4% 15.1%
Rev Growth +24.4% +24.4% +20.9% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 75.59M 72.54M
Total Equity 144.13M 160.68M
D/E Ratio 0.52 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -21,227,905 -16,209,717 37.89M 33.02M
Free Cash Flow 31.87M 21.95M